259 related articles for article (PubMed ID: 21773024)
1. Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
Sun G; Kashyap SR
J Nutr Metab; 2011; 2011():708183. PubMed ID: 21773024
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.
Shlomai G; Neel B; LeRoith D; Gallagher EJ
J Clin Oncol; 2016 Dec; 34(35):4261-4269. PubMed ID: 27903154
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links.
Gristina V; Cupri MG; Torchio M; Mezzogori C; Cacciabue L; Danova M
Biomed Rep; 2015 Mar; 3(2):131-136. PubMed ID: 25798235
[TBL] [Abstract][Full Text] [Related]
4. Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease.
Martens FM; van der Graaf Y; Dijk JM; Olijhoek JK; Visseren FL
Atherosclerosis; 2008 Apr; 197(2):646-53. PubMed ID: 17374372
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Moran LJ; Misso ML; Wild RA; Norman RJ
Hum Reprod Update; 2010; 16(4):347-63. PubMed ID: 20159883
[TBL] [Abstract][Full Text] [Related]
6. [Diabetes mellitus in Spain: death rates, prevalence, impact, costs and inequalities].
Ruiz-Ramos M; Escolar-Pujolar A; Mayoral-Sánchez E; Corral-San Laureano F; Fernández-Fernández I
Gac Sanit; 2006 Mar; 20 Suppl 1():15-24. PubMed ID: 16539961
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic characteristics associated with type 2 diabetes.
Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J
Rev Clin Esp (Barc); 2014 Apr; 214(3):121-30. PubMed ID: 24359793
[TBL] [Abstract][Full Text] [Related]
8. More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
Dankner R; Roth J
Diabet Med; 2020 Feb; 37(2):194-202. PubMed ID: 31769894
[TBL] [Abstract][Full Text] [Related]
9. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
Kraniotou C; Karadima V; Bellos G; Tsangaris GT
J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico.
Herrera MF; García-García E; Arellano-Ramos JF; Madero MA; Aldrete-Velasco JA; Corvalá JAL
Obes Surg; 2018 Nov; 28(11):3474-3483. PubMed ID: 29915971
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people - The WATCH study.
Koller KR; Metzger JS; Jolly SE; Umans JG; Hopkins SE; Kaufmann C; Wilson AS; Ebbesson SO; Raymer TW; Austin MA; Howard BV; Boyer BB
Diabetes Res Clin Pract; 2015 Jun; 108(3):423-31. PubMed ID: 25805711
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of diabetes mellitus type 2].
Soriguer F; Rubio-Martín E; Rojo-Martínez G
Med Clin (Barc); 2012 Dec; 139(14):640-6. PubMed ID: 22622178
[TBL] [Abstract][Full Text] [Related]
13. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
López-Jaramillo P; Barbosa E; Molina DI; Sanchez R; Diaz M; Camacho PA; Lanas F; Pasquel M; Accini JL; Ponte-Negretti CI; Alcocer L; Cobos L; Wyss F; Sebba-Barroso W; Coca A; Zanchetti A;
J Hypertens; 2019 Jun; 37(6):1126-1147. PubMed ID: 30882601
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
Wannamethee SG; Shaper AG; Lennon L; Morris RW
Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
[TBL] [Abstract][Full Text] [Related]
15. The linkage between inflammation and Type 2 diabetes mellitus.
Cruz NG; Sousa LP; Sousa MO; Pietrani NT; Fernandes AP; Gomes KB
Diabetes Res Clin Pract; 2013 Feb; 99(2):85-92. PubMed ID: 23245808
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic hypotension in diabetic patients-10-year follow-up study.
Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
[TBL] [Abstract][Full Text] [Related]
17. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
[TBL] [Abstract][Full Text] [Related]
18. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and cancer, common threads and missing links.
Hua F; Yu JJ; Hu ZW
Cancer Lett; 2016 Apr; 374(1):54-61. PubMed ID: 26879686
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
